Journal of Hematology & Oncology

Title Publication Date Language Citations
Retraction Note: Genomic amplification and high expression of EGFR are key targetable oncogenic events in malignant peripheral nerve sheath tumor2022/10/27English
Journal of Hematology & Oncology reviewer acknowledgement 20122013/03/28English
What's new in the management of chronic lymphocytic leukemia? 2008 ASH Review (New York Medical College, January 31, 2009)2009/06/01English
Molecular target therapy – towards curative regimen: a 20-year experience in the treatment of acute promyelocytic leukemia (APL) in the Shanghai Institute of Hematology2009/06/01English
Overcoming Gleevec-resistance by blocking oncogene addiction in malignant hematologic cells2012/04/25English
Utilizing CD30 expression as a rational target for therapy of lymphoma2012/04/25English
Epstein - Barr virus - associated Diseases in Allogeneic Hematopoietic Stem Cell Transplantation2012/04/25English
Recent advances in myelodysplasia: update from 2011 ASH annual meeting2012/04/25English
Restoration of T cell tolerance in primary ITP2012/04/25English
Targeted therapy in head/neck and gastric cancers2012/04/25English
Journal of Hematology & Oncology reviewer acknowledgement 20142015/03/04English
Journal of Hematology & Oncology reviewer acknowledgement 20132014/02/05English
Journal of Hematology & Oncology reviewer acknowledgement 20152016/03/02English
Perioperative versus adjuvant S-1 plus oxaliplatin chemotherapy for stage II/III resectable gastric cancer (RESONANCE): a randomized, open-label, phase 3 trial2024/04/08English
Safety and antitumor activity of metformin plus lanreotide in patients with advanced gastro-intestinal or lung neuroendocrine tumors: the phase Ib trial MetNET22023/12/14English
Multiscale protein networks systematically identify aberrant protein interactions and oncogenic regulators in seven cancer types2023/12/15English
Direct inhibition of dioxygenases TET1 by the rheumatoid arthritis drug auranofin selectively induces cancer cell death in T-ALL2023/11/22English
Outcomes of patients with secondary central nervous system lymphoma following CAR T-cell therapy: a multicenter cohort study2023/11/09English
Decoding the glycoproteome: a new frontier for biomarker discovery in cancer2024/03/22English
Targeted protein degradation in hematologic malignancies: latest updates from the 2023 ASH annual meeting2024/03/22English
Targeting inflammation as cancer therapy2024/03/22English
Proteomic characterization of esophageal squamous cell carcinoma response to immunotherapy reveals potential therapeutic strategy and predictive biomarkers2024/03/15English
Optical nanomaterial-based detection of biomarkers in liquid biopsy2024/03/14English
Identification of SARS-CoV-2-specific T cell and its receptor2024/03/27English
Hyperhomocysteinemia potentiates megakaryocyte differentiation and thrombopoiesis via GH-PI3K-Akt axis2023/07/27English
Conventional and novel [18F]FDG PET/CT features as predictors of CAR-T cell therapy outcome in large B-cell lymphoma2024/04/23English
Heterodimerization of T cell engaging bispecific antibodies to enhance specificity against pancreatic ductal adenocarcinoma2024/04/23English
Epigenetic regulation of diverse cell death modalities in cancer: a focus on pyroptosis, ferroptosis, cuproptosis, and disulfidptosis2024/04/23English
Efficacy and safety of bendamustine for lymphodepletion before lisocabtagene maraleucel2024/04/22English
Chemo-free treatment of adult patients with Ph-positive acute lymphoblastic leukemia: latest updates from the 2023 ASH annual meeting2024/04/16English